Literature DB >> 34297178

Progressive cortical and sub-cortical alterations in patients with anti-N-methyl-D-aspartate receptor encephalitis.

Jinping Xu1, Yuanyuan Guo2, Jiaying Li1, Xinyi Lv3, Juanjuan Zhang2, Jinhuan Zhang1, Qingmao Hu4, Kai Wang5,6,7,8,9, Yanghua Tian10,11,12,13.   

Abstract

BACKGROUND: Advanced structural analyses are increasingly being highly valued to uncover pathophysiological understanding of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Therefore, we aimed to explore whether and how antibody-mediated NMDAR dysfunction affected cortical and sub-cortical brain morphology and their relationship with clinical symptoms.
METHODS: We performed surface-based morphometry analyses, hippocampal segmentation, and correlational analyses in 24 patients with anti-NMDAR encephalitis after acute disease stage and 30 normal controls (NC) in this case-control study.
RESULTS: Patients showed significantly decreased cortical alterations mainly in language network (LN) and default mode network (DMN), as well as decreased gray matter volume in left cornu ammonis 1 (CA1) body of hippocampus. Further correlation analyses showed that the decreased cortical thickness in the right superior frontier gyrus was associated with decreased cognitive scores, the decreased cortical volume in the right pars triangulari and decreased surface area in the right pars operculari were associated with decreased memory scores, whereas decreased gray matter volume in the left CA1 body was significantly correlated with longer time between first symptom and imaging in the patients.
CONCLUSION: These results suggested that cognitive impairments resulted from long-term sequelae of the encephalitis were mainly associated with cortical alterations in LN and DMN and sub-cortical atrophy of left CA1 body, which can be served as effective features to assess disease progression in clinical routine examination.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anti-N-methyl-D-aspartate receptor encephalitis; Cortical thickness; Gray matter volume; Surface area; Surface-based morphology

Mesh:

Year:  2021        PMID: 34297178     DOI: 10.1007/s00415-021-10643-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  48 in total

1.  Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review.

Authors:  Gemma L McKeon; Gail A Robinson; Alexander E Ryan; Stefan Blum; David Gillis; Carsten Finke; James G Scott
Journal:  J Clin Exp Neuropsychol       Date:  2017-06-06       Impact factor: 2.475

2.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

Review 3.  Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: A systematic review.

Authors:  Stephen Bacchi; Kyle Franke; Dasith Wewegama; Edward Needham; Sandy Patel; David Menon
Journal:  J Clin Neurosci       Date:  2018-03-28       Impact factor: 1.961

4.  Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome.

Authors:  T Zhang; Y Duan; J Ye; W Xu; N Shu; C Wang; K Li; Y Liu
Journal:  AJNR Am J Neuroradiol       Date:  2018-03-22       Impact factor: 3.825

Review 5.  Imaging of autoimmune encephalitis--Relevance for clinical practice and hippocampal function.

Authors:  J Heine; H Prüss; T Bartsch; C J Ploner; F Paul; C Finke
Journal:  Neuroscience       Date:  2015-05-23       Impact factor: 3.590

6.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

7.  Brain magnetic resonance-imaging findings of anti-N-methyl-D-aspartate receptor encephalitis: a cohort follow-up study in Chinese patients.

Authors:  Rui Wang; Xiao-Hui Lai; Xu Liu; Yu-Jia Li; Chu Chen; Chen Li; Xiao-Sa Chi; Dong Zhou; Zhen Hong
Journal:  J Neurol       Date:  2017-12-16       Impact factor: 4.849

8.  Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis.

Authors:  Marienke A A M de Bruijn; Femke K Aarsen; Marielle P van Oosterhout; Marieke M van der Knoop; Coriene E Catsman-Berrevoets; Marco W J Schreurs; Danielle E M Bastiaansen; Peter A E Sillevis Smitt; Rinze F Neuteboom; Maarten J Titulaer
Journal:  Neurology       Date:  2018-04-27       Impact factor: 9.910

Review 9.  A clinical approach to diagnosis of autoimmune encephalitis.

Authors:  Francesc Graus; Maarten J Titulaer; Ramani Balu; Susanne Benseler; Christian G Bien; Tania Cellucci; Irene Cortese; Russell C Dale; Jeffrey M Gelfand; Michael Geschwind; Carol A Glaser; Jerome Honnorat; Romana Höftberger; Takahiro Iizuka; Sarosh R Irani; Eric Lancaster; Frank Leypoldt; Harald Prüss; Alexander Rae-Grant; Markus Reindl; Myrna R Rosenfeld; Kevin Rostásy; Albert Saiz; Arun Venkatesan; Angela Vincent; Klaus-Peter Wandinger; Patrick Waters; Josep Dalmau
Journal:  Lancet Neurol       Date:  2016-02-20       Impact factor: 44.182

Review 10.  Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis.

Authors:  Julia Deakin; Belinda R Lennox; Michael S Zandi
Journal:  Biol Psychiatry       Date:  2013-08-26       Impact factor: 13.382

View more
  1 in total

1.  Cerebral gray matter volume changes in patients with anti-N-methyl-D-aspartate receptor encephalitis: A voxel-based morphometry study.

Authors:  Qijia Long; Zongxia Lv; Jingyuan Zhao; Ke Shi; Chunyan Li; Binglin Fan; Jinou Zheng
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.